
Cure JM’s 20th Year Opens With the Promise of Four New Research Grants
Research Grants: New Grantees and Exciting Updates From Existing Grant Recipients This year saw a very strong field of grant applications across a variety of
Juvenile myositis is a rare autoimmune disease in which the body’s immune system attacks its own cells and tissues. Your doctor may refer to juvenile myositis as juvenile dermatomyositis or JDM. Juvenile dermatomyositis is the most common form of the disease.
Juvenile myositis affects each child differently as the immune system typically attacks muscle and skin, resulting in significant and sometimes severe weakness and persistent rash. The exact cause of JM is unknown. Current treatments are imperfect yet have reduced the mortality rate to less than 3%.
Research Grants: New Grantees and Exciting Updates From Existing Grant Recipients This year saw a very strong field of grant applications across a variety of
Juvenile myositis, including juvenile dermatomyositis and juvenile polymyositis, is a group of rare and life-threatening autoimmune diseases, in which the body’s immune system attacks its
A world-renowned pediatric rheumatologist and immunologist tells us what juvenile dermatomyositis (JDM) is, how it is diagnosed, and how it is treated.
A treatment plan is based on many factors, including the severity and expression of the juvenile dermatomyositis (JDM). Each case is different and the symptoms
Example images of JM symptoms including calcinosis, skin rashes, gottron papules, lipodystrophy, heliotrope eyelids, plaquenil reactions, and steroid effects.
Having a chronic and rare disease is a challenging experience for anyone to go through, and especially difficult on children and adolescents.
This comprehensive guide features over 450 pages with contributions from over 80 experts and medical professionals.
Receive a free digital copy when you join Cure JM here.